REPL
Replimune Group, Inc. · Healthcare
Executive Chair Philip Astley-Sparke sold $493K of Replimune Group, Inc.
Sold$493,290
$17.01Price
29,000Shares
−2%Stake
What REPL did after the filing
Prices for REPL after this filing aren't in yet.
Traded Wed, Nov 6. Filed Fri, Nov 8, 9:16 PM ET, after the close. Not investment advice.